VIP antagonists and uses in treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11471506
APP PUB NO 20210046152A1
SERIAL NO

17050376

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to methods of treating cancer or viral infections comprising administering an effective amount of a VIP antagonist in combination with an immune check-point inhibitor to a subject in need thereof. In certain embodiments, the immune check-point inhibitor is an anti-PD1 or anti-PDL1 antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EMORY UNIVERSITY; GEORGIA TECH RESEARCH CORPORATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pankove, Rebecca Atlanta, US 3 0
Ravindranathan, Sruthi Atlanta, US 4 0
Thomas, Susan Atlanta, US 4 8
Waller, Edmund K Atlanta, US 18 146

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00